A Study of JNJ-55308942 in the Treatment of Bipolar Depression
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05328297 |
Recruitment Status :
Recruiting
First Posted : April 14, 2022
Last Update Posted : March 27, 2024
|
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Information provided by (Responsible Party):
Janssen Pharmaceutica N.V., Belgium
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 22, 2024 |
Estimated Study Completion Date : | May 21, 2024 |